Midwest Trust Co Invests $323,000 in Amdocs Limited $DOX

Midwest Trust Co bought a new stake in shares of Amdocs Limited (NASDAQ:DOX) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 3,544 shares of the technology company’s stock, valued at approximately $323,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Alyeska Investment Group L.P. lifted its holdings in Amdocs by 38.6% during the 1st quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company’s stock valued at $213,174,000 after buying an additional 648,693 shares in the last quarter. American Century Companies Inc. grew its stake in Amdocs by 23.5% in the 1st quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company’s stock worth $205,219,000 after acquiring an additional 426,911 shares in the last quarter. Nuveen LLC purchased a new position in shares of Amdocs during the first quarter worth approximately $36,921,000. LSV Asset Management increased its position in shares of Amdocs by 11.1% during the first quarter. LSV Asset Management now owns 3,180,501 shares of the technology company’s stock worth $291,016,000 after acquiring an additional 317,412 shares during the period. Finally, AQR Capital Management LLC increased its position in shares of Amdocs by 43.0% during the first quarter. AQR Capital Management LLC now owns 955,158 shares of the technology company’s stock worth $86,719,000 after acquiring an additional 287,243 shares during the period. 92.02% of the stock is currently owned by institutional investors.

Amdocs Stock Performance

Shares of NASDAQ:DOX opened at $77.36 on Thursday. The firm has a 50 day moving average of $83.34 and a 200 day moving average of $87.41. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $8.73 billion, a price-to-earnings ratio of 15.69, a price-to-earnings-growth ratio of 1.40 and a beta of 0.51. Amdocs Limited has a 52 week low of $76.50 and a 52 week high of $95.41.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, November 11th. The technology company reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.82 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The business had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same period last year, the business posted $1.70 EPS. The business’s revenue was down 9.0% compared to the same quarter last year. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. On average, sell-side analysts predict that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be given a $0.527 dividend. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.7%. Amdocs’s payout ratio is presently 42.60%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on DOX shares. Bank of America lowered their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday. Stifel Nicolaus decreased their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday. Wall Street Zen cut Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research report on Thursday, October 30th. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $101.67.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.